Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dimitrov

Showing results (371-380 of 442) with videos related to

Pageof 45
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|June 19, 2024
The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancerJiawei Zhang, Junjun Liu, Yali Yue, et al.
Molecular and Cellular Endocrinology|September 18, 2012
Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signallingAimee J Varewijck, Michael P Brugts, Jan Frystyk, et al.
Journal of Virology|May 3, 2014
Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodiesTianlei Ying, Lanying Du, Tina W Ju, et al.
Viruses|May 27, 2023
A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic HenipavirusesMoushimi Amaya, Randy Yin, Lianying Yan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2004
Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120Chih-chin Huang, Miro Venturi, Shahzad Majeed, et al.
Journal for Immunotherapy of Cancer|December 2, 2022
GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapiesGuillem Pascual-Pasto, Brendan McIntyre, Rawan Shraim, et al.
Plos One|September 13, 2012
Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41Mei-Yun Zhang, Tingting Yuan, Jingjing Li, et al.
ACS Omega|November 29, 2023
Assessment of Novel Mesothelin-Specific Human Antibody Domain VH-Fc Fusion Proteins-Based PET AgentsZehua Sun, Ambika P Jaswal, Xiaojie Chu, et al.
Energy & Environmental Science|January 10, 2017
Reduced voltage losses yield 10% efficient fullerene free organic solar cells with >1 V open circuit voltagesD Baran, T Kirchartz, S Wheeler, et al.
Journal of Virology|February 28, 2006
Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletionMichele Di Mascio, Irini Sereti, Lynn T Matthews, et al.
Pageof 45

Showing results (371-380 of 442) with videos related to

Sort By:
Pageof 45
Journal of Experimental & Clinical Cancer Research : CR|June 19, 2024
The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancerJiawei Zhang, Junjun Liu, Yali Yue, et al.
Molecular and Cellular Endocrinology|September 18, 2012
Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signallingAimee J Varewijck, Michael P Brugts, Jan Frystyk, et al.
Journal of Virology|May 3, 2014
Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodiesTianlei Ying, Lanying Du, Tina W Ju, et al.
Viruses|May 27, 2023
A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic HenipavirusesMoushimi Amaya, Randy Yin, Lianying Yan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2004
Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120Chih-chin Huang, Miro Venturi, Shahzad Majeed, et al.
Journal for Immunotherapy of Cancer|December 2, 2022
GPC2 antibody-drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapiesGuillem Pascual-Pasto, Brendan McIntyre, Rawan Shraim, et al.
Plos One|September 13, 2012
Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41Mei-Yun Zhang, Tingting Yuan, Jingjing Li, et al.
ACS Omega|November 29, 2023
Assessment of Novel Mesothelin-Specific Human Antibody Domain VH-Fc Fusion Proteins-Based PET AgentsZehua Sun, Ambika P Jaswal, Xiaojie Chu, et al.
Energy & Environmental Science|January 10, 2017
Reduced voltage losses yield 10% efficient fullerene free organic solar cells with >1 V open circuit voltagesD Baran, T Kirchartz, S Wheeler, et al.
Journal of Virology|February 28, 2006
Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletionMichele Di Mascio, Irini Sereti, Lynn T Matthews, et al.
Pageof 45